MREO
Mereo BioPharma GroupDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MREO vs peer average
54/100
MREO vs. peer average (D vs. D)
Grade spread
C 2 · D 4 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Aligos is a loose same-cap clinical biotech comparator where valuation is also driven more by milestone timing and funding capacity than by current revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MREO
Mereo BioPharma Group
ALGS
Aligos Therapeutics
Grade
D
D
Momentum
91
65
Value
41
41
Sentiment
45
47
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ALGS
MREO / ALGS
Grade Position
In line
MREO vs. peer average (D vs. D)
54/100
Momentum
91
MREOValue
41
MREOSentiment
45
ALGSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MREO
ALGS is the first peer returned for this comparison set.